Key result
Over a 10-year period (2011-2020), rates of in-hospital neurological deterioration, mortality, and recurrent stroke decreased, while functional outcomes remained unchanged.
Why the study?
The study was designed to evaluate decade-long temporal trends in advanced treatments and clinical outcomes of ischemic stroke using nationwide multicenter registry data, and to identify areas needing improvement.
Cohort (n=77,662)
Yes
Answers are grounded in this paper and cite their sources.
Over a decade in South Korea, advancements in acute and preventive stroke management were associated with reduced mortality and recurrent stroke, though functional outcomes did not improve.
Background This study aims to evaluate temporal trends of advanced treatments and related clinical outcomes of ischemic stroke through a decade‐long trend analysis, using data from a comprehensive, national, multicenter registry. We also seek to identify areas in need of improvement. Methods and Results This analysis involved patients with ischemic stroke or transient ischemic attack registered prospectively in the CRCS‐K‐NIH (Clinical Research Center for Stroke in Korea–National Institute of Health) registry between 2011 and 2020. We examined temporal trends in risk factors, pathogenetic subtypes, acute management strategies, and outcomes for up to 1 year following a stroke. Generalized linear mixed models were used to account for center clustering. The average age of 77 662 patients increased 2.2 years in men and 2.4 years in women over the 10‐year follow‐up. Notably, in‐hospital neurological deterioration, 3‐month and 1‐year mortality rate, and cumulative incidence of recurrent stroke within 1‐year decreased over time after adjustments for age, sex, and initial stroke severity ( P <0.01). However, functional outcomes at 3 months and 1 year remained unchanged. Endovascular thrombectomy increased from 5.4% in 2011 to 10.6% in 2020. Use of anticoagulants for atrial fibrillation, dual antiplatelet therapy, statins, and stroke unit care also increased. Contrarily, the rate of intravenous thrombolysis showed a slight decline. Conclusions This study points to a reduction in death and risk of recurrent stroke over the past decade, paralleling enhancement in acute and preventive stroke management. Nevertheless, the decline in the use of intravenous thrombolysis and the lack of improvement in functional outcomes following stroke are concerning trends that warrant thorough investigation.
No takes yet. Share an insight, caveat, or question.
Park et al. (2025) conducted a cohort in ischemic stroke or transient ischemic attack (n=77,662). Temporal trends in stroke management (2011-2020) was evaluated on in-hospital neurological deterioration, 3-month and 1-year mortality rate, and cumulative incidence of recurrent stroke within 1-year (p=<0.01). Over a 10-year period (2011-2020), rates of in-hospital neurological deterioration, mortality, and recurrent stroke decreased, while functional outcomes remained unchanged.
Synapse has enriched 10 related papers. Consider them for comparative context: